Patent Establishes Important IP Milestone for the Company and Validates Initial Database Discovery System
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Selventa™, which evolved from Genstruct®, Inc. today announced that the U.S. Patent & Trademark Office has issued the Company U.S. Patent No 7,865,534, titled “System, Method and Apparatus for Assembling and Mining Life Science Data.”
This patent describes an in silico-based data storage system that allows scientists to systematically capture, store and update computer-operable biological representations based on life science ontologies. This system uses machine-readable symbolic representations that are constraint-based to ensure that the encoded complex life science knowledge is semantically rigorous.
“We are pleased with the grant of this patent by the U.S. Patent Office,” said David de Graaf, Ph.D., President and CEO of Selventa. “This patent is a recognition of Selventa’s competitive IP position and it validates to our partners a key technological tool for their development programs.”
Founded in 2002 and privately-held, Selventa helps clients find optimal treatments for the right patients by offering scientific consulting services, software and strategic partnerships. The company analyzes molecular patient data, accelerates the development process and clarifies therapeutics and diagnostics decisions. Selventa engages in short-, mid- and long-term relationships with top-tier pharmaceutical and life science companies to develop new therapeutics and mechanistic biomarkers in the areas of oncology, metabolic disorders, cardiovascular diseases, inflammation and drug safety. For more information, visit www.selventa.com.
KEYWORDS: United States North America Massachusetts
INDUSTRY KEYWORDS: Technology Data Management Health Biotechnology Clinical Trials Oncology Pharmaceutical Research Science